Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6.

In conclusion, DAAs are effective and may be safe for the treatment of chronic hepatitis C genotypes 5 and 6. However, our evidence is based on noncomparative studies; hence, further larger-scale randomized controlled trials in these genotypes are still required. PMID: 31815126 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31815126?dopt=Abstract

Source: Biomed Res - December 11, 2019 Category: Research Authors: Due OT, Chaikledkaew U, Genuino AJM, Sobhonslidsuk A, Thakkinstian A Tags: Biomed Res Int Source Type: research